Chimerism after liver transplantation for type IV glycogen storage disease and type 1 Gaucher's disease.

PubWeight™: 3.36‹?› | Rank: Top 1%

🔗 View Article (PMC 2963442)

Published in N Engl J Med on March 18, 1993

Authors

T E Starzl1, A J Demetris, M Trucco, C Ricordi, S Ildstad, P I Terasaki, N Murase, R S Kendall, M Kocova, W A Rudert

Author Affiliations

1: Pittsburgh Transplant Institute, University of Pittsburgh Health Science Center.

Articles citing this

Cell migration and chimerism after whole-organ transplantation: the basis of graft acceptance. Hepatology (1993) 8.76

Murine liver allograft transplantation: tolerance and donor cell chimerism. Hepatology (1994) 4.32

Donor cell chimerism permitted by immunosuppressive drugs: a new view of organ transplantation. Immunol Today (1993) 4.29

Antigen localization and migration in immunity and tolerance. N Engl J Med (1998) 3.71

Systemic chimerism in human female recipients of male livers. Lancet (1992) 3.63

Variable chimerism, graft-versus-host disease, and tolerance after different kinds of cell and whole organ transplantation from Lewis to brown Norway rats. Transplantation (1995) 3.63

Chimerism and donor-specific nonreactivity 27 to 29 years after kidney allotransplantation. Transplantation (1993) 3.13

Outcome analysis of 71 clinical intestinal transplantations. Ann Surg (1995) 2.95

Hematolymphoid cell trafficking, microchimerism, and GVH reactions after liver, bone marrow, and heart transplantation. Transplant Proc (1993) 2.81

Clinical intestinal transplantation: new perspectives and immunologic considerations. J Am Coll Surg (1998) 2.31

Mobilization of host stem cells enables long-term liver transplant acceptance in a strongly rejecting rat strain combination. Am J Transplant (2011) 2.26

Transplantation milestones. Viewed with one- and two-way paradigms of tolerance. JAMA (1995) 2.20

Microchimerism, dendritic cell progenitors and transplantation tolerance. Stem Cells (1995) 1.83

Glycogen storage diseases: new perspectives. World J Gastroenterol (2007) 1.67

Transplantation tolerance, microchimerism, and the two-way paradigm. Theor Med Bioeth (1998) 1.67

The biological basis of and strategies for clinical xenotransplantation. Immunol Rev (1994) 1.56

Split tolerance induced by orthotopic liver transplantation in mice. Transplantation (1994) 1.52

Liver transplantation for glycogen storage disease types I, III, and IV. Eur J Pediatr (1999) 1.30

Spontaneous and iatrogenically augmented leukocyte chimerism in organ transplant recipients. Transplant Proc (1994) 1.29

Augmentation of chimerism in whole organ recipients by simultaneous infusion of donor bone marrow cells. Transplant Proc (1995) 1.24

Donor species complement after liver xenotransplantation. The mechanism of protection from hyperacute rejection. Transplantation (1994) 1.21

Tolerance to noninherited maternal antigens in mice and humans. Curr Opin Organ Transplant (2009) 1.09

Chimerism and tolerance in transplantation. Proc Natl Acad Sci U S A (2004) 1.07

Epstein-Barr virus, infectious mononucleosis, and posttransplant lymphoproliferative disorders. Transplant Sci (1994) 1.06

Acquired immunologic tolerance: with particular reference to transplantation. Immunol Res (2007) 0.97

The unfinished legacy of liver transplantation: emphasis on immunology. Hepatology (2006) 0.93

Temporary withdrawal of immunosuppression for life-threatening infections after liver transplantation. Transplantation (1994) 0.91

History of clinical transplantation. World J Surg (2000) 0.91

Augmentation of natural chimerism with donor bone marrow in orthotopic liver recipients. Transplant Proc (1996) 0.90

Living Donor Liver Transplantation in a Korean Child with Glycogen Storage Disease Type IV and a GBE1 Mutation. Gut Liver (2009) 0.90

Glycogenosis type IV: liver transplant at 12 years. Arch Dis Child (1994) 0.87

Improved neutrophil function in a glycogen storage disease type 1b patient after liver transplantation. Eur J Pediatr (2004) 0.86

The future of transplantation: with particular reference to chimerism and xenotransplantation. Transplant Proc (1997) 0.83

Recent advances in hepatic transplantation at the University of Pittsburgh. Clin Transpl (1993) 0.83

The Future of Xenotransplantation. Ann Surg (1992) 0.80

HLA matching and the point system. Clin Transplant (1993) 0.80

A strategy for organ allografts without using immunosuppressants or irradiation. Proc Natl Acad Sci U S A (1998) 0.79

The dichotomous functions of passenger leukocytes in solid-organ transplantation. Adv Nephrol Necker Hosp (1995) 0.79

Liver transplantation in glycogen storage disease type I. Orphanet J Rare Dis (2014) 0.78

Mixed chimerism and immunologic tolerance. N Engl J Med (1993) 0.78

The two-way paradigm of transplantation immunology. Clin Immunol Immunopathol (1996) 0.78

Cardiac Involvement in Glycogen Storage Disease Type IV: Two Cases and the Two Ends of a Spectrum. Case Rep Med (2012) 0.77

The birth of clinical organ transplantation. J Am Coll Surg (2001) 0.76

Liver disease. Postgrad Med J (1994) 0.76

Ingraft chimerism in lung transplantation--a study in a porcine model of obliterative bronchiolitis. Respir Res (2011) 0.76

Hepatic transplantation at the University of Pittsburgh: new horizons and paradigms after 30 years of experience. Clin Transpl (1994) 0.76

Xenobiotics, chimerism and the induction of tolerance following organ transplantation. Ther Immunol (1994) 0.76

The current status of hepatic transplantation at the University of Pittsburgh. Clin Transpl (1995) 0.76

Chimerism after Whole Organ Transplant. Guthrie J Donald Guthrie Found Med Res (1993) 0.75

Regulation of immune reactivity and tolerance by antigen migration and localization: with particular reference to allo- and xenotransplantation. Transplant Proc (1999) 0.75

The basis of allograft acceptance. Forum (Genova) (1997) 0.75

The Role of Cell Migration and Chimerism in Organ Transplant Acceptance and Tolerance Induction. Transplant Sci (1993) 0.75

Liver transplantation for pediatric inherited metabolic disorders: Considerations for indications, complications, and perioperative management. Pediatr Transplant (2016) 0.75

Current perspectives of transplantation immunology via the intestine. Transplant Proc (1996) 0.75

Exosomes: The missing link between microchimerism and acquired tolerance? Chimerism (2015) 0.75

The bidirectional paradigm of transplant immunology. Ann N Y Acad Sci (1995) 0.75

Host stem cells repopulate liver allografts: reverse chimerism. Chimerism (2012) 0.75

Clinical variability in neurohepatic syndrome due to combined mitochondrial DNA depletion and Gaucher disease. Mol Genet Metab Rep (2014) 0.75

Correlation of donor antigen-specific hyporeactivity with allogeneic microchimerism in kidney and lung recipients. Pediatr Nephrol (1995) 0.75

Articles cited by this

The dendritic cell system and its role in immunogenicity. Annu Rev Immunol (1991) 23.09

Identification of a novel cell type in peripheral lymphoid organs of mice. I. Morphology, quantitation, tissue distribution. J Exp Med (1973) 13.88

Cell migration, chimerism, and graft acceptance. Lancet (1992) 12.24

Induction of immunological tolerance by porcine liver allografts. Nature (1969) 5.89

Restoration of immunogenicity to passenger cell-depleted kidney allografts by the addition of donor strain dendritic cells. J Exp Med (1982) 5.09

Systemic chimerism in human female recipients of male livers. Lancet (1992) 3.63

Heart-liver transplantation in a patient with familial hypercholesterolaemia. Lancet (1984) 2.91

Liver transplantation to provide low-density-lipoprotein receptors and lower plasma cholesterol in a child with homozygous familial hypercholesterolemia. N Engl J Med (1984) 2.44

Anomalous ABO phenotype in a child after an ABO-incompatible liver transplantation. N Engl J Med (1992) 2.36

Liver transplantation for type IV glycogen storage disease. N Engl J Med (1991) 2.31

Isohemagglutinins of graft origin after ABO-unmatched liver transplantation. N Engl J Med (1984) 2.25

Demonstration of a deficiency of glucocerebroside-cleaving enzyme in Gaucher's disease. J Clin Invest (1966) 2.01

Lack of an alpha-1,4-glucan: alpha-1,4-glucan 6-glycosyl transferase in a case of type IV glycogenosis. Proc Natl Acad Sci U S A (1966) 1.72

Expression of major histocompatibility complex antigens and replacement of donor cells by recipient ones in human liver grafts. Transplantation (1987) 1.65

The application of bone marrow transplantation to the treatment of genetic diseases. Science (1986) 1.62

Donor dendritic cells after liver and heart allotransplantation under short-term immunosuppression. Lancet (1992) 1.61

Severe graft-versus-host disease in a liver-transplant recipient. N Engl J Med (1988) 1.59

Replacement therapy for inherited enzyme deficiency: liver orthotopic transplantation in Niemann-Pick disease type A. Am J Med Genet (1977) 1.51

Cell migration and chimerism--a unifying concept in transplantation--with particular reference to HLA matching and tolerance induction. Transplant Proc (1993) 1.40

Donor dendritic cell repopulation in recipients after rat-to-mouse bone-marrow transplantation. Lancet (1992) 1.32

Graft vs. host disease after liver transplantation in humans: a report of four cases. Hepatology (1991) 1.13

Correction of enzymatic deficiencies by renal transplantation: Fabry's disease. Surgery (1972) 1.13

Liver transplantation for cholesteryl ester storage disease. J Pediatr Gastroenterol Nutr (1991) 1.08

Molecular compatibility and renal graft survival--the HLA DRB1 genotyping. Transplantation (1993) 1.04

Lessons from genetic disorders of lysosomes. Harvey Lect (1982) 0.95

Orthotopic liver transplantation for type 1 Gaucher's disease. Transplantation (1992) 0.92

Continuing lessons from glycogen storage diseases. N Engl J Med (1991) 0.91

Articles by these authors

FK 506 for liver, kidney, and pancreas transplantation. Lancet (1989) 13.70

Cell migration, chimerism, and graft acceptance. Lancet (1992) 12.24

High association of an HL-A antigen, W27, with ankylosing spondylitis. N Engl J Med (1973) 9.90

The Banff 97 working classification of renal allograft pathology. Kidney Int (1999) 9.02

Cell migration and chimerism after whole-organ transplantation: the basis of graft acceptance. Hepatology (1993) 8.76

Bone marrow as a potential source of hepatic oval cells. Science (1999) 8.52

Serotyping for homotransplantation. 18. Refinement of microdroplet lymphocyte cytotoxicity test. Transplantation (1968) 8.51

The use of cyclosporin A and prednisone in cadaver kidney transplantation. Surg Gynecol Obstet (1980) 7.40

Microdroplet testing for HLA-A, -B, -C, and -D antigens. The Phillip Levine Award Lecture. Am J Clin Pathol (1978) 6.88

Long survival in rats after multivisceral versus isolated small-bowel allotransplantation under FK 506. Surgery (1991) 5.92

Bone marrow augmentation of donor-cell chimerism in kidney, liver, heart, and pancreas islet transplantation. Lancet (1994) 5.54

Significance of the positive crossmatch test in kidney transplantation. N Engl J Med (1969) 5.50

Banff '05 Meeting Report: differential diagnosis of chronic allograft injury and elimination of chronic allograft nephropathy ('CAN'). Am J Transplant (2007) 5.39

Liver, kidney, and thoracic organ transplantation under FK 506. Ann Surg (1990) 5.01

Autologous stimulation of human lymphocyte subpopulation. J Exp Med (1975) 4.80

Liver transplantation (1). N Engl J Med (1989) 4.53

Cytotoxins in disease. Autocytotoxins in lupus. N Engl J Med (1970) 4.40

Murine liver allograft transplantation: tolerance and donor cell chimerism. Hepatology (1994) 4.32

Donor cell chimerism permitted by immunosuppressive drugs: a new view of organ transplantation. Immunol Today (1993) 4.29

Pancreatic islet transplantation after upper abdominal exenteration and liver replacement. Lancet (1990) 4.18

Serotyping for homotransplantation. X. Survival of 196 grafted kidneys subsequent to typing. Transplantation (1967) 4.16

Shwartzman reaction after human renal homotransplantation. N Engl J Med (1968) 4.05

Baboon-to-human liver transplantation. Lancet (1993) 4.01

The insulin gene is transcribed in the human thymus and transcription levels correlated with allelic variation at the INS VNTR-IDDM2 susceptibility locus for type 1 diabetes. Nat Genet (1997) 3.70

Kidney preservation for transportation. Initial perfusion and 30 hours' ice storage. Lancet (1969) 3.67

Systemic chimerism in human female recipients of male livers. Lancet (1992) 3.63

Variable chimerism, graft-versus-host disease, and tolerance after different kinds of cell and whole organ transplantation from Lewis to brown Norway rats. Transplantation (1995) 3.63

Hepatic resection versus transplantation for hepatocellular carcinoma. Ann Surg (1991) 3.57

Canine kidney transplantation with FK-506 alone or in combination with cyclosporine and steroids. Transplant Proc (1987) 3.55

Long-term survival after renal transplantation in humans: (with special reference to histocompatibility matching, thymectomy, homograft glomerulonephritis, heterologous ALG , AND RECIPIENT MALIGNANCY). Ann Surg (1970) 3.48

Banff 2013 meeting report: inclusion of c4d-negative antibody-mediated rejection and antibody-associated arterial lesions. Am J Transplant (2014) 3.43

Effect of blood transfusions on subsequent kidney transplants. Transplant Proc (1973) 3.42

Orthotopic liver transplantation for patients with hepatitis B virus-related liver disease. Hepatology (1991) 3.34

Early trials with FK 506 as primary treatment in liver transplantation. Transplant Proc (1990) 3.29

Banff '09 meeting report: antibody mediated graft deterioration and implementation of Banff working groups. Am J Transplant (2010) 3.29

Use of OKT3 with cyclosporin and steroids for reversal of acute kidney and liver allograft rejection. Nephron (1987) 3.26

The pathology of posttransplant lymphoproliferative disorders occurring in the setting of cyclosporine A-prednisone immunosuppression. Am J Pathol (1988) 3.24

Nomenclature for factors of the HLA system, 2010. Tissue Antigens (2010) 3.22

Rejection of multivisceral allografts in rats: a sequential analysis with comparison to isolated orthotopic small-bowel and liver grafts. Surgery (1990) 3.18

Pathology of hepatic transplantation: A review of 62 adult allograft recipients immunosuppressed with a cyclosporine/steroid regimen. Am J Pathol (1985) 3.16

Chimerism and donor-specific nonreactivity 27 to 29 years after kidney allotransplantation. Transplantation (1993) 3.13

Orthotopic liver transplantation in dogs receiving FK-506. Transplant Proc (1987) 3.11

Effect of pravastatin on outcomes after cardiac transplantation. N Engl J Med (1995) 3.11

Age-related osteogenic potential of mesenchymal stromal stem cells from human vertebral bone marrow. J Bone Miner Res (1999) 3.05

Chronic survival after human renal homotransplantation. Lymphocyte-antigen matching, pathology and influence of thymectomy. Ann Surg (1965) 3.00

Expression of Epstein-Barr virus-encoded small RNA (by the EBER-1 gene) in liver specimens from transplant recipients with post-transplantation lymphoproliferative disease. N Engl J Med (1992) 2.98

Liver transplantation (2). N Engl J Med (1989) 2.93

Dilated cardiomyopathy in transgenic mice with cardiac-specific overexpression of tumor necrosis factor-alpha. Circ Res (1997) 2.91

Long-term survival after liver transplantation in 4,000 consecutive patients at a single center. Ann Surg (2000) 2.91

Trends in childhood type 1 diabetes incidence in Europe during 1989-2008: evidence of non-uniformity over time in rates of increase. Diabetologia (2012) 2.85

The lost chord: microchimerism and allograft survival. Immunol Today (1996) 2.81

Hematolymphoid cell trafficking, microchimerism, and GVH reactions after liver, bone marrow, and heart transplantation. Transplant Proc (1993) 2.81

Cadaveric small bowel and small bowel-liver transplantation in humans. Transplantation (1992) 2.75

THE IMMUNOSUPPRESSIVE EFFECTS OF FR 900506 IN RATS RECEIVING HETEROTOPIC CARDIAC ALLOGRAFTS. Surg Res Commun (1987) 2.75

Detection of Y chromosome sequences in Turner's syndrome by Southern blot analysis of amplified DNA. Lancet (1993) 2.65

A review of adult and pediatric post-transplant liver pathology. Pathol Annu (1987) 2.62

Improvement of kidney-graft survival with increased numbers of blood transfusions. N Engl J Med (1978) 2.52

FK506 "rescue" for resistant rejection of renal allografts under primary cyclosporine immunosuppression. Transplantation (1994) 2.50

Transplantation of kidneys from donors whose hearts have stopped beating. N Engl J Med (1998) 2.48

Propagation of dendritic cell progenitors from normal mouse liver using granulocyte/macrophage colony-stimulating factor and their maturational development in the presence of type-1 collagen. J Exp Med (1994) 2.48

Association of primary sclerosing cholangitis with HLA-DRw52a. N Engl J Med (1990) 2.40

Persistent differences among centers over 3 years in glycemic control and hypoglycemia in a study of 3,805 children and adolescents with type 1 diabetes from the Hvidøre Study Group. Diabetes Care (2001) 2.37

Toxicology of FK-506 in the Lewis rat. Transplant Proc (1987) 2.37

Thoracic duct drainage before and after cadaveric kidney transplantation. Surg Gynecol Obstet (1979) 2.33

Liver transplantation for type IV glycogen storage disease. N Engl J Med (1991) 2.31

Clinical intestinal transplantation: new perspectives and immunologic considerations. J Am Coll Surg (1998) 2.31

FK 506 in clinical kidney transplantation. Transplant Proc (1991) 2.29

Differential survival of hamster-to-rat liver and cardiac xenografts under FK 506 immunosuppression. Transplant Proc (1991) 2.28

Banff 2011 Meeting report: new concepts in antibody-mediated rejection. Am J Transplant (2012) 2.28

Evidence for superantigen involvement in insulin-dependent diabetes mellitus aetiology. Nature (1994) 2.25